Chemical Structure (Naproxen 01)
Naproxen Tablet, Delayed Release
Product Images NDC 11534-211
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 11534-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sunrise Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (375 mg Tablet Bottle Label)
This is a product label for Naproxen tablets containing 375 mg of naproxen. The tablets are delayed-release and come in a package of 100 tablets. The package is child-resistant and should be stored in light-resistant containers at 20° to 25°C (68° to 77°F). The medication guide should be dispensed to each patient by the pharmacist. The tablets are distributed by Sunrise Pharmaceutical, Inc. in Rahway, NJ.*
Principal Display Panel (500 mg Tablet Bottle Label)
This is information about a medication with the NDC number 11534-212-01, Naproxen. Each tablet contains 500 mg of naproxen in delayed-release form. The packaging includes 100 tablets. The usual dosage instructions can be found in the package insert. The medication should be stored at 20°C to 25°C. It is recommended to dispense in light-resistant containers. This medication is distributed by Sunrise Pharmaceutical, located in Rahway, NJ 07065. The revision date is 09/25. *
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
